Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Nautilus Biotechnology Q4 EPS $(0.13), Inline

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate.
byBenzinga Newsdesk
February 24, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For Synnex

By Benzinga Insights
Today, 5:57 AM
Synnex (NYSE:SNX) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here's what investors need to know before the announcement. Analysts estimate that Synnex will report an earnings per share (EPS) of $2.74.

SNX